What is the evidence for Retatrutide?
Retatrutide has meaningful randomized human evidence, but it should not be described as an available approved alternative to semaglutide or tirzepatide.
DIRECT ANSWER
Retatrutide evidence summary.
Retatrutide has meaningful randomized human evidence, but it should not be described as an available approved alternative to semaglutide or tirzepatide.
Reviewed August 7, 2026. Each statement links to its evidence record, followed by the primary and official sources used for this answer.
Randomized Phase 2 trials are published and Phase 3 development is underway; the drug remains investigational.
Open evidence recordPreclinical work supports triple-receptor pharmacology, but human trials are the decision-relevant evidence.
Open evidence recordPromising trial results do not establish approval, product quality outside trials, or suitability for an individual.
Open evidence recordPRIMARY & OFFICIAL SOURCES
Sources for this answer.
3 source records, with duplicates removed.